RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma
Open Access
- 18 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 12 (6), e10979
- https://doi.org/10.15252/emmm.201910979
Abstract
Drugs that mobilise the immune system against cancer are dramatically improving care for many people. Dying cancer cells play an active role in inducing anti‐tumour immunity but not every form of death can elicit an immune response. Moreover, resistance to apoptosis is a major problem in cancer treatment and disease control. While the term “immunogenic cell death” is not fully defined, activation of receptor‐interacting serine/threonine‐protein kinase 1 (RIPK1) can induce a type of death that mobilises the immune system against cancer. However, no clinical treatment protocols have yet been established that would harness the immunogenic potential of RIPK1. Here, we report the first pre‐clinical application of an in vivo treatment protocol for soft‐tissue sarcoma that directly engages RIPK1‐mediated immunogenic cell death. We find that RIPK1‐mediated cell death significantly improves local disease control, increases activation of CD8+ T cells as well as NK cells, and enhances the survival benefit of immune checkpoint blockade. Our findings warrant a clinical trial to assess the survival benefit of RIPK1‐induced cell death in patients with advanced disease at limb extremities.Funding Information
- Breast Cancer Now (CTR‐QR14‐007)
- Cancer Research UK (CRM089X)
- Royal College of Surgeons of England (160729)
- Sarcoma UK (SUK203.2016, SUK203.2017)
- Rosetrees Trust (A1292)
This publication has 62 references indexed in Scilit:
- 20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose MattersAnnals of Surgical Oncology, 2011
- cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP IsoformsMolecular Cell, 2011
- Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinomaOncogene, 2011
- Radiotherapy for Soft Tissue Sarcomas after Isolated Limb Perfusion and Surgical Resection: Essential for Local Control in All Patients?Annals of Surgical Oncology, 2010
- IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancerNature Reviews Cancer, 2010
- IAP-targeted therapies for cancerOncogene, 2008
- Smac Mimetics and TNFα: A Dangerous Liaison?Cell, 2007
- Endogenously Generated Hydrogen Peroxide Is Required for Execution of Melphalan-Induced Apoptosis as Well as Oxidation and Externalization of PhosphatidylserineChemical Research in Toxicology, 2004
- Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP ProteinsCell, 2000
- Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactionsEuropean Journal of Cancer and Clinical Oncology, 1982